1605PDHealth-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line. (23rd October 2018) - Grünwald, V; Schuler, M; Schöffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L H; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Richter, S; et al.